Strand Therapeutics Competitors and Similar CompaniesClear all

Strand Therapeutics's competitors and similar companies include Ayala Pharmaceuticals, Corestem, Triumvira and Sanofi.

	Strand Therapeutics Strand Therapeutics is a company that develops mRNA-based therapeutics with programmable genetic circuits.	Ayala Pharmaceuticals Ayala Pharmaceuticals is a clinical-stage biopharmaceutical company developing medicines for cancers that are genetically defined.	Corestem Corestem (코아스템) is a biopharmaceutical company that researches and commercializes stem cell technology.	Triumvira Triumvira Immunologics is an immunotherapy company.	Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Founding Date	Founding Date 2017	Founding Date 2017	Founding Date 2003	Founding Date 2015	Founding Date 1994
Type	Type Private	Type Public	Type Public	Type Private	Type Public
Tags	Tags Technology bioengineering biotech genetics medtech pharma therapy	Tags Healthcare Technology biotech drug development life sciences oncology pharma therapy	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech drug development life sciences pharma therapy	Tags Healthcare biotech drug development life sciences pharma therapy
Locations	Locations Boston, US HQ	Locations Wilmington, US HQ Rehovot, IL Wilmington, US	Locations Seongnam-si, KR HQ	Locations Austin, US HQ Hamilton, CA	Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more
Employees	Employees 1022% increase	Employees 29	Employees 354	Employees 287% decrease	Employees 82,878
Valuation ($)	Valuation ($) N/A	Valuation ($) 7.4 m	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 141.1 b
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $692k (FY, 2022)	Revenue (est.) ₩28.8b (FY, 2024)	Revenue (est.) N/A	Revenue (est.) €45.4b (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $602k (FY, 2022)	Cost of goods ₩25.6b (FY, 2024)	Cost of goods N/A	Cost of goods €11.6b (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $90k (FY, 2022)	Gross profit ₩5.6b (FY, 2024)	Gross profit N/A	Gross profit €37.6b (FY, 2025)
Net income	Net income N/A	Net income ($38m) (FY, 2022)	Net income (₩26.3b) (FY, 2024)	Net income N/A	Net income €8b (FY, 2025)
Funding
Latest funding round	Latest funding round $ 45m (over 3 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 55m (almost 6 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 6m	Total funding raised $ 47m	Total funding raised N/A	Total funding raised $ 55m	Total funding raised $ 310m